Search for: "KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC." Results 1 - 20 of 40
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2023, 4:15 am by Allan Blutstein
So, I agree that Barnes is a welcome development. [read post]
4 Oct 2019, 4:38 pm by Unknown
It is also familiar wisdom that this limited capacity influences the Court’s decisions and development of constitutional doctrine, albeit in diffuse and indeterminate ways. [read post]
13 Sep 2019, 6:00 am by Guest Blogger
And to the extent that the justices have internalized such second-order attitudes about the extent to which they should hold back on effectuating their first-order attitudes, these second-order attitudes may offer an alternative explanation for why the Court has often developed doctrines that restrain even the first-order attitudes of those who have developed and internalized them. [read post]
2 Nov 2018, 7:32 pm by Schachtman
Merrill Dow Pharmaceuticals, Inc., 874 F.2d 307, 311-12 (5th Cir. 1989) (“Fortunately, we do not have to resolve any of the above questions [as to bias and confounding], since the studies presented to us incorporate the possibility of these factors by the use of a confidence interval. [read post]
9 Nov 2015, 7:09 am
  In fact, product liability law often follows a “needs of the many” approach that supports research, development, and limitation of liability for prescription medical products, where large damage awards can occur in the Wink of an Eye and can result in The Doomsday Machine for such products. [read post]
25 Apr 2015, 11:03 am by Schachtman
It is apparent from epidemiological data that some people can engage in chain smoking for many decades without developing lung cancer. [read post]
9 Apr 2015, 11:59 am by Lawrence B. Ebert
Chien, Of Trolls, Davids, Goliaths, and Kings: Narratives and Evidence in the Litigation of High-Tech Patents, 87 N.C. [read post]
2 Feb 2015, 2:20 am
Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) reports on the Hague Court of Appeal’s summary ruling in a case between Novartis AG and Sun Pharmaceutical Industries BV. [read post]
3 May 2014, 8:56 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 89 F.3d 594, 596-98 (9th Cir. 1996) (affirming exclusion of Dr. [read post]
19 Sep 2013, 12:35 pm
Cuevas conducted research projects for UHP senior management on Integrated Delivery Systems to help the organization develop strategic plans to adjust to the changing care delivery models and incentives system. [read post]
10 Jun 2012, 1:09 pm by Schachtman
For example, women with herpes are more likely to develop cervical cancer than other women. [read post]
27 Aug 2011, 7:55 pm
This is "the sport of kings," that only large corporations can play. [read post]
4 May 2011, 7:52 am by Tron Emptage
Barry Lipton, Chris Laws and Linda Li, “Narcotics in Workers Compensation,” NCCI Research Brief, December 2009 p.5. 8. [read post]
14 May 2010, 4:00 am by FDABlog HPM
District Court for the District of New Jersey (King Pharmaceuticals Inc., King Pharmaceuticals Research and Development Inc., Pharmaceutical IP Holding Inc. v. [read post]